intermittent theta-burst stimulation (iTBS)
intermittent theta-burst stimulation (iTBS) is a medical device with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Multicenter iTBS Neuromodulation for PTSD Treatment
Intermittent Theta-Burst Stimulation (iTBS) as an add-on to Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Post-traumatic Stress Disorder (PTSD)
Exploring the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation
Adjunctive iTBS for First-Episode Schizophrenia
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
Clinical Trials (8)
Multicenter iTBS Neuromodulation for PTSD Treatment
Intermittent Theta-Burst Stimulation (iTBS) as an add-on to Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Post-traumatic Stress Disorder (PTSD)
Exploring the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation
Adjunctive iTBS for First-Episode Schizophrenia
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
Intermittent Theta-Burst Stimulation to Target Irritability in Adults With ASD
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
Exploring the Cortical Hemodynamic Response of Excitatory Brain Stimulation: a Pilot Study
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8